• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Leukotriene receptor antagonists role in recuding the cardiovascular and cerebrovascular risk: A case-control study in southern Spain
Background and Aims: Leukotriene receptor antagonists (LTRAs) are used in asthmatic patients, however different studies indicate that LTRAs can decrease intimal hyperplasia after vascular injury, and have a protective role in cerebral ischemia. The aim of our study was to assess the role of LTRAs in reducing myocardial infarction (MI) and ischemic stroke (IS) risk in patients from two Primary Health Care Centers of Granada.
Source: Atherosclerosis - December 1, 2020 Category: Cardiology Authors: M. Hoxha, V. Malaj, C. Rivilla Doce, A.B. Cavanillas Source Type: research

Cardiovascular Incomes In The Hypertensive And Diabetic Mediterranean Population Older Than 65 Years Old
Background and Aims: In Spain, hypertension and DM are major health problems. The importance of determining the CV risk associated with both is based on the evidence of simultaneous CV risk factors potentiate each other, giving rise to a total CV risk that is greater than the sum of its components. Our objective was to study the income from coronary heart disease, heart failure or stroke produced in these patients during follow-up.
Source: Atherosclerosis - August 4, 2019 Category: Cardiology Authors: B. Roig-Espert, J.J. Tamarit-Garc ía, A. González-Cruz-Cervellera, V. Pallarés-Carratalá, P. Morillas-Blasco Tags: Posters 26 - 29 May, 2019 Source Type: research

Distribution of lipoprotein (a) in a population with cardiovascular events or dyslipidaemia
Aim: High level of lipoprotein(a) has been demonstrated to be an independent cardiovascular risk factor. However epidemiological data about Lp(a) levels in different patient cohorts are scarce. We aim to describe values of Lp(a) in a population of northern Spain with high cardiovascular risk (stroke or acute myocardial infarction) or dyslipidaemia.
Source: Atherosclerosis - August 1, 2018 Category: Cardiology Authors: A.R. Guerra Ruiz, B.A. Lavin Gomez, E.J. Palacio Portilla, Y. Jimenez Lopez, J.L. Hernandez Hernandez, C. Garc ía Ibarbia, N. Royuela Martinez, M.T. Garcia Unzueta, J.A. Vazquez de Prada Source Type: research